Developing Immunotherapeutic Technologies to Combat Infectious Disease and Cancer With Dr. Tim Rodell Aethlon Medical TRANSCRIPT
Download PDFAug 31, 2020
Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent...
Aug 31, 2020
Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent...
Using Immunotherapy to Treat Glioblastoma Most Aggressive Brain Cancer with Dr. Apostolos Stathopoulos ERC Immunotherapy TRANSCRIPT
Download PDFAug 5, 2020
Apostolos Stathopoulos, CEO, ERC-Belgium talks about using immunotherapy to treat glioblastoma, the most malignant of all gliomas or brain cancers. ERC's therapy, which stimulates the patient's immune system to mount an immune response against the tumor cells, has demonstrated a clinically meaningful survival benefit...
Aug 5, 2020
Apostolos Stathopoulos, CEO, ERC-Belgium talks about using immunotherapy to treat glioblastoma, the most malignant of all gliomas or brain cancers. ERC's therapy, which stimulates the patient's immune system to mount an immune response against the tumor cells, has demonstrated a clinically meaningful survival benefit...
Immunocytokines Platform Superagonist Activates T-cells and NK Cells to Fight Solid Tumors With Jens Hennecke SOTIO TRANSCRIPT
Download PDFJul 22, 2020
Jens Hennecke, Chief Business Officer, SOTIO explains how this biotech company is developing the next generation of immunotherapies with a focus on a new compound called SO-C101 based on the cytokine IL-15, the key cytokine that activates T-cells and NK cells. In clinical trials, this drug, a modified IL-15 does not...